Daniel P Dever

Title: The Innovations of Daniel P Dever

Introduction

Daniel P Dever is a notable inventor based in Stanford, CA. He has made significant contributions to the field of gene therapy and genome editing. With a total of 3 patents, his work focuses on advancing medical treatments through innovative methodologies.

Latest Patents

One of his latest patents is titled "Pharmaceutical compositions comprising gene-corrected primary cells." This invention provides methods for inducing stable gene modifications in primary cells, such as blood and mesenchymal cells. The invention also includes methods for enriching genetically modified primary cells with targeted integration at specific nucleic acids. Another significant patent is "Nuclease-mediated genome editing of primary cells," which similarly outlines methods for stable gene modification and the introduction of DNA nucleases to facilitate targeted integration. These inventions aim to prevent or treat diseases by administering genetically modified primary cells or pharmaceutical compositions to affected subjects.

Career Highlights

Daniel P Dever has worked with prestigious organizations, including Leland Stanford Junior University and Boco Silicon Valley, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to gene therapy.

Collaborations

Throughout his career, Dever has collaborated with notable individuals such as Rasmus O Bak and Ayal Hendel. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Daniel P Dever's contributions to the field of gene therapy and genome editing are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.